Initiatives to reduce postoperative surgical site infections of the head and neck cancer surgery with a special emphasis on developing countries

Expert Review of Anticancer Therapy

Volumn 19, Issue 1, 2019, Pages 81-92

  Haque, Mainul ^a   McKimm, Judy ^b   Godman, Brian ^c,d,e   Abu Bakar, Muhamad ^a   Sartelli, Massimo ^f  

^a NATIONAL DEFENCE UNIVERSITY OF MALAYSIA   (Malaysia)

^b SWANSEA UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e Sasako Makgatho Health Sciences University   (South Africa)

^f MACERATA HOSPITAL   (Italy)

Author keywords

cancer; head; Healthcare; neck; postoperative; surgery; surgical site infections

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFAZOLIN; CLINDAMYCIN; GENTAMICIN; LINEZOLID; MEROPENEM; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; BACTERIOLOGY; CANCER PATIENT; CANCER SURGERY; DEVELOPING COUNTRY; HEAD AND NECK CANCER; HUMAN; INFECTION RISK; NONHUMAN; POSTOPERATIVE INFECTION; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SURGICAL INFECTION; HEAD AND NECK TUMOR; PROCEDURES;

ANTIBIOTIC PROPHYLAXIS; DEVELOPING COUNTRIES; HEAD AND NECK NEOPLASMS; HUMANS; QUALITY OF LIFE; RISK FACTORS; SURGICAL WOUND INFECTION;

EID: 85058782419     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1080/14737140.2019.1544497     Document Type: Review

References (136)

1. Weber WP, Marti WR, Zwahlen M, et al. The timing of surgical antimicrobial prophylaxis. Ann Surg. 2008;247(6):918–926.
2. Young PY, Khadaroo RG., Surgical site infections. Surg Clinics North Am. 2014;94(6):1245–1264.
3. Legesse Laloto T, Hiko Gemeda D, Abdella SH. Incidence and predictors of surgical site infection in Ethiopia: prospective cohort. BMC Infect Dis. 2017;17(1):119.
4. Anderson DJ, Podgorny K, Berrios-Torres SI, et al. Strategies to prevent surgical site infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014;35(Suppl 2):s66–88.
5. Purba AKR, Setiawan D, Bathoorn E, et al. Prevention of surgical site infections: a systematic review of cost analyses in the use of prophylactic antibiotics. Front Pharmacol. 2018;9:776.
6. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999;20(4):250–278.
7. Silvestri A, Brandi C, Grimaldi L, et al. Octyl-2-cyanoacrylate adhesive for skin closure and prevention of infection in plastic surgery. Aesthetic Plast Surg. 2006;30(6):695–699.
8. Anderson DJ, Sexton DJ, Kanafani ZA, et al. Severe surgical site infection in community hospitals: epidemiology, key procedures, and the changing prevalence of methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol. 2007;28(9):1047–1053.
9. O’Hara LM, Thom KA, Preas MA. Update to the centers for disease control and prevention and the healthcare infection control practices advisory committee guideline for the prevention of surgical site infection (2017): a summary, review, and strategies for implementation. Am J Infect Control. 2018;46(6):602–609.
10. Korol E, Johnston K, Waser N, et al. A systematic review of risk factors associated with surgical site infections among surgical patients. PloS one. 2013;8(12):e83743.
11. Allegranzi B, Bagheri Nejad S, Combescure C, et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet. 2011;377(9761):228–241.
12. Singhal H. Wound infection clinical presentation. Drug and disease, general surgery. Medscape 2017. https://emedicine.medscape.com/article/188988-clinical. [Accessed on May -19 - 2018].
13. Cai LZ, Chang J, Weiser TG, et al. Surgical site infections after tissue flaps performed in low- and middle-human development index countries: a systematic review. Surg Infect. 2017;18(7):765–773.
14. Opanga SA, Mwang’ombe NJ, Okalebo FA, et al. Determinants of the effectiveness of antimicrobial prophylaxis among neurotrauma patients at a referral hospital in kenya: findings and implications. Infect Dis Preve Med. 2017;5(3):169.
15. Ngaroua, Ngah JE, Bénet T, et al. Incidence of surgical site infections in sub-Saharan Africa: systematic review and meta-analysis. Pan Afr Med J. 2015;24:171.
16. National Healthcare Safety Network, Centers for Disease Control and Prevention. Surgical site infection (SSI) event. 2018. Available at http://www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf [Accessed on May - 19 - 2018].
17. Zimlichman E, Henderson D, Tamir O, et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med. 2013;173(22):2039–2046.
18. Department of Health and Human Services (DHHS). National Action Plan to Prevent Healthcare-Associated Infections: Roadmap to Elimination. Available at http://www.hhs.gov/ash/initiatives/hai/infection.html [May 20, 2018]
19. Magill SS, Hellinger W, Cohen J, et al. Prevalence of healthcare-associated infections in acute care hospitals in Jacksonville, Florida. Infect Control Hosp Epidemiol. 2012;33(3):283–291.
20. European Centre for Disease Prevention and Control. Point prevalence survey of healthcare associated infections and antimicrobial use in European acute care hospitals 2011. Available at http://ecdc.europa.eu/en/publications/Publications/healthcare-associated-infections-antimicrobial-use-PPS.pdf [Accessed on May -19 - 2018].
21. Coello R, Charlett A, Wilson J, et al. Adverse impact of surgical site infections in english hospitals. J Hosp Infect. 2005;60(2):93–103.
22. Fraioli R, Johnson JT. Prevention and treatment of postsurgical head and neck infections. Curr Infect Dis Rep. 2004;6:172–180.
23. Mandell-Brown M, Johnson JT, Wagner RL. Cost-effectiveness of prophylactic antibiotics in head and neck surgery. Otolaryngol Head Neck Surg. 1984;92(5):520–523.
24. Mañós M, Giralt J, Rueda A, et al. Multidisciplinary management of head and neck cancer: first expert consensus using Delphi methodology from the Spanish society for head and neck cancer (part 1). Oral Oncol. 2017;70:58–64.
25. Rueda A, Giralt J, Mañós M, et al. Multidisciplinary manag of head and neck cancer: first expert consensus using Delphi methodology from the Spanish society for head and neck cancer (part 2). Oral Oncol. 2017;70:65–72.
26. Denaro N, Merlano MC, Russi EG. Follow-up in head and neck cancer: do more does it mean do better? a systematic review and our proposal based on our experience. Clin Exp Otorhinolaryngol. 2016;9(4):287–297.
27. Machiels J-P, Lambrecht M, Hanin F-X, et al. Advances in the management of squamous cell carcinoma of the head and neck. F1000Prime Rep. 2014;6:44.
28. Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Allen C, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017; 3(4):524–548.
29. International Agency for Research on Cancer. world health organisation. Globocan 2012. Estimated cancer incidence, mortality and prevalence worldwide in 2012. Available at http://globoscan.iarc.fr [Accessed on October-11-2018]
30. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality,and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24(14):2137–2150.
31. Rischin D, Ferris RL, Le QT. Overview of advances in head and neck cancer. J Clin Oncol. 2015;33(29):3225–3226.
32. Otoh EC, Johnson NW, Danfillo IS, et al. Primary head and neck cancers in North Eastern Nigeria. West Afr J Med. 2004;23(4):305–313.
33. Gilyoma JM, Rambau PF, Masalu N, et al. Head and neck cancers: a clinico-pathological profile and management challenges in a resource-limited setting. BMC Res Notes. 2015;8:772.
34. Silver CE, Rinaldo A, Ferlito A. Crile’s neck dissection. Laryngoscope. 2007;117(11):1974–1977.
35. Rinaldo A, Ferlito A, Silver CE. Early history of neck dissection. Eur Arch Otorhinolaryngol. 2008;265(12):1535–1538.
36. Hamoir M, Schmitz S, Gregoire V. The role of neck dissection in squamous cell carcinoma of the head and neck. Curr Treat Options Oncol. 2014;15(4):611–624.
37. Marks SC. Surgical management of head and neck cancer. Hematol Oncol Clin North Am. 1999;13(4):655–678.
38. Penel N, Lefebvre D, Fournier C, et al. Risk factors for wound infection in head and neck cancer surgery: a prospective study. Head Neck. 2001;23(6):447–455.
39. Cannon RB, Houlton JJ, Mendez E, et al. Methods to reduce postoperative surgical site infections after head and neck oncology surgery. Lancet Oncol. 2017;18(7):e405–e13.
40. Rao MK, Reilley TE, Schuller DE, et al. Analysis of risk factors for postoperative pulmonary complications in head and neck surgery. Laryngoscope. 1992;102(1):45–47.
41. McCulloch TM, Jensen NF, Girod DA, et al. Risk factors for pulmonary complications in the postoperative head and neck surgery patient. Head Neck. 1997;19(5):372–377.
42. Pohlenz P, Blessmann M, Heiland M, et al. Postoperative complications in 202 cases of microvascular head and neck reconstruction. J Craniomaxillofac Surg. 2007;35(6–7):311–315.
43. Joo Y, Sun D, Cho J, et al. Factors that predict postoperative pulmonary complications after supracricoid partial laryngectomy. Arch Otolaryngol Head Neck Surg. 2009;135(11):1154–1157.
44. Petrar S, Bartlett C, Hart RD, et al. Pulmonary complications after major head and neck surgery: a retrospective cohort study. Laryngoscope. 2012;122(5):1057–1061.
45. Panda NK, Shaf M, Patro SK, et al. Changing trends in antibiotic prophylaxis in head and neck surgery: is short-term prophylaxis feasible?. J Head Neck Physicians Surg. 2016;4(1):42–48.
46. Sydnor ERM, Perl TM. Hospital Epidemiology and Infection Control in Acute-Care Settings. Clin Microbiol Rev. 2011;24(1):141–173.
47. Park J, Seale H. Examining the online approaches used by hospitals in Sydney, Australia to inform patients about healthcare-associated infections and infection prevention strategies. BMC Infect Dis. 2017;17:788.
48. Okoth C, Opanga S, Okalebo F, et al. Point prevalence survey of antibiotic use and resistance at a referral hospital in Kenya: findings and implications. Hospital Pract. 2018;46(3):128–136.
49. Mwita JC, Souda S, Magafu M, et al. Prophylactic antibiotics to prevent surgical site infections in Botswana: findings and implications. Hospital Pract. 2018;46(3):97–102.
50. Tiroyakgosi C, Matome M, Summers E, et al. Ongoing initiatives to improve the use of antibiotics in Botswana: university of Botswana symposium meeting report. Expert Rev Anti Infect Ther. 2018;16(5):381–384.
51. Ban KA, Minei JP, Laronga C, et al. Executive Summary of the American college of surgeons/surgical infection society surgical site infection guidelines-2016 update. Surg Infect. 2017;18(4):379–382.
52. Bratzler DW, Houck PM. Surgical infection prevention guidelines writers workgroup, et al. Antimicrobial Prophylaxis for Surgery: an Advisory Statement from the National Surgical Infection Prevention Project. Clinical Infect Dis. 2004;38(12):1706–1715.
53. Veve MP, Greene JB, Williams AM, et al. Multicenter assessment of antibiotic prophylaxis spectrum on surgical infections in head and neck cancer microvascular reconstruction. Otolaryngol Head Neck Surg. 2018;159(1):59–67.
54. Durand ML, Yarlagadda BB, Rich DL, et al. The time course and microbiology of surgical site infections after head and neck free flap surgery. Laryngoscope. 2015;125(5):1084–1089.
55. Penel N, Fournier C, Lefebvre D, et al. Multivariate analysis of risk factors for wound infection in head and neck squamous cell carcinoma surgery with opening of mucosa. Study of 260 Surgical Procedures. Oral Oncol. 2005;41(3):294–303.
56. Atieno OM, Opanga S, Martin A, et al. Pilot study assessing the direct medical cost of treating patients with cancer in Kenya; findings and implications for the future. J Med Econ. 2018;21(9):878–887.
57. National Cancer Institute. What are cancers of the head and neck? https://www.cancer.gov/types/head-and-neck/head-neck-fact-sheet#q1. cited 2018 Sept1
58. Marur S, Forastiere AA. Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2008;83(4):489–501.
59. Vigneswaran N, Williams MD. Epidemiological trends in head and neck cancer and aids in diagnosis. Oral Maxillofac Surg Clin North Am. 2014;26(2):123–141.
60. Deschler DG, Richmon JD, Khariwala SS, et al. The “new” head and neck cancer patient—young, nonsmoker, nondrinker, and hpv positive: evaluation. Otolaryngol Head Neck Surg. 2014;151(3):375–380.
61. Majchrzak E, Szybiak B, Wegner A, et al. Oral cavity and oropharyngeal squamous cell carcinoma in young adults: a review of the literature. Radiol Oncol. 2014;48(1):1–10.
62. Hashibe M, Brennan P, Chuang SC, et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the international head and neck cancer epidemiology consortium. Cancer Epidemiol Biomarkers Prev. 2009;18:541–550.
63. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45(4–5):309–316.
64. Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?. Cancer. 2007;110(7):1429–1435.
65. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24–35.
66. Gillison ML. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol. 2004;31(6):744–754.
67. Sturgis EM, Kk A. The epidemic of HPV-associated oropharyngeal cancer is here: is it time to change our treatment paradigms?. J Natl Compr Cancnetw. 2011;9:665–673.
68. Schnipper LE, Davidson NE, Wollins DS, et al. American society of clinical oncology statement: a conceptual framework to assess the value of cancer treatment options. J Clin Oncol. 2015;33(23):2563–2577.
69. Mwita JC, Souda S, Magafu MGMD, et al. Prophylactic antibiotics to prevent surgical site infections in Botswana: findings and implications. Hosp Pract. 2018;46(3):97–102.
70. Najjar PA, Smink DS. Prophylactic antibiotics and prevention of surgical site infections. Surg Clin North Am. 2015;95(2):269–283.
71. Yao CM, Ziai H, Tsang G, et al. Surgical site infections following oral cavity cancer resection and reconstruction is a risk factor for plate exposure. J Otolaryngol Head Neck Surg. 2017;46(1):30.
72. Shigeishi H, Ohta K, Takechi M. Risk factors for postoperative complications following oral surgery. J Appl Oral Sci. 2015;23(4):419–423.
73. Smolka W, Iizuka T. Surgical reconstruction of maxilla and midface: clinical outcome and factors relating to postoperative complications. J Craniomaxillofac Surg. 2005;33(1):1–7.
74. Lee DH, Kim SY, Nam SY, et al. Risk factors of surgical site infection in patients undergoing major oncological surgery for head and neck cancer. Oral Oncol. 2011;47(6):528–531.
75. Ogihara H, Takeuchi K, Majima Y. Risk factors of postoperative infection in head and neck surgery. Auris Nasus Larynx. 2009;36(4):457–460.
76. Lin SC, Chang TS, Yang KC, et al. Factors contributing to surgical site infection in patients with oral cancer undergoing microvascular free flap reconstruction. Eur Arch Otorhinolaryngol. 2018;275(8):2101–2108.
77. Cunha TF, Soares Melancia TA. Zagalo Fernandes Ribeiro CM, et al. Risk Factors for Surgical Site Infection in Cervico-Facial Oncological Surgery. J Craniomaxillofac Surg. 2012;40(5):443–448.
78. Park SY, Kim MS, Eom JS, et al. Risk factors and etiology of surgical site infection after radical neck dissection in patients with head and neck cancer. Korean J Int Med. 2016;31(1):162–169.
79. Negi V, Pal S, Juyal D, et al. Bacteriological profile of surgical site infections and their antibiogram: a study from resource constrained rural setting of Uttarakhand state, India. J Clin Diagn Res. 2015;9(10):DC17–DC20.
80. Pool C, Kass J, Spivack J, et al. Increased surgical site infection rates following clindamycin use in head and neck free tissue transfer. Otolaryngol Head Neck Surg. 2016;154(2):272–278.
81. Sumathi BG. Bacterial pathogens of surgical site infections in cancer patients at a tertiary regional cancer centre, South India. Int J Curr Microbiol App Sci. 2016;5(10):605–616.
82. Reichman DE, Greenberg JA. Reducing surgical site infections: a review. Rev Obstet Gynecol. 2009;2(4):212–221.
83. Ottoline ACX, Tomita S, Marques M Da PC, et al. Antibiotic prophylaxis in otolaryngologic surgery. Int Arch of Otorhinolaryngol. 2013;17(1):85–91.
84. Kreutzer K, Storck K, Weitz J. Current evidence regarding prophylactic antibiotics in head and neck and maxillofacial surgery. BioMed Res Int. 2014;2014:879437.
85. Simo R, French G. The use of prophylactic antibiotics in head and neck oncological surgery. Curr Opin Otolaryngol Head Neck Surg. 2006;14(2):55–61.
86. Man LX, Beswick DM, Johnson JT. Antibiotic prophylaxis in uncontaminated neck dissection. Laryngoscope. 2011;121(7):1473–1477.
87. Veve MP, Davis SL, Williams AM, et al. Considerations for antibiotic prophylaxis in head and neck cancer surgery. Oral Oncol. 2017;74:181–187.
88. Humphreys H, Coia JE, Stacey A, et al. Healthcare infection society. Guidelines on the Facilities Required for Minor Surgical Procedures and Minimal Access Interventions. J Hosp Infect. 2012;80(2):103–109.
89. Global Guidelines for the Prevention of Surgical Site Infection. Geneva: world health organization. 2016. 4, Evidence-Based Recommendations On Measures For The Prevention Of Surgical Site Infection. Available at https://www.ncbi.nlm.nih.gov/books/NBK401151/[Accessed on October 19-2018]
90. Bartella AK, Kamal M, Teichmann J, et al. Prospective comparison of perioperative antibiotic management protocols in oncological head and neck surgery. J Craniomaxillofac Surg. 2017;45(7):1078–1082.
91. Wagner JL, Kenny RM, Vazquez JA, et al. Surgical prophylaxis with gram-negative activity for reduction of surgical site infections after microvascular reconstruction for head and neck cancer. Head Neck. 2016;38(10):1449–1454.
92. Veve MP, Davis SL, Williams AM, et al. Considerations for antibiotic prophylaxis in head and neck cancer surgery. Oral Oncol. 2017;74:181–187.
93. Johnson JT, Myers EN, Thearle PB, et al. Antimicrobial prophylaxis for contaminated head and neck surgery. Laryngoscope. 1984;94(1):46–51.
94. Haidar YM, Tripathi PB, Tjoa T, et al. Antibiotic prophylaxis in clean-contaminated head and neck cases with microvascular free flap reconstruction: A systematic review and meta-analysis. Head Neck. 2018;40(2):417–427.
95. Langerman A, Thisted R, Hohmann S, et al. Antibiotic and duration of perioperative prophylaxis predicts surgical site infection in head and neck surgery. Otolaryngol Head Neck Surg. 2016;154(6):1054–1063.
96. Mitchell RM, Mendez E, Schmitt NC, et al. Antibiotic prophylaxis in patients undergoing head and neck free flap reconstruction. JAMA Otolaryngol Head Neck Sur. 2015;141(12):1096–2103.
97. Nathwani D, Sneddon J, Patton A, et al. Antimicrobial stewardship in Scotland: impact of a national program. Antimicrob Resist Infect Control. 2012;1(1):7.
98. Pulcini C, Mainardi JL. Antimicrobial stewardship: an international emergency. Clin Microbiol Infect. 2014;20(10):947–948.
99. Davey P, Marwick CA, Scott CL, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. The Cochrane Database of Systematic Reviews. 2017;2:Cd003543.
100. Nakwatumbah S, Kibuule D, Godman B, et al. Compliance to guidelines for the prescribing of antibiotics in acute infections at Namibia’s national referral hospital: a pilot study and the implications. Expert Rev Anti Infect Ther. 2017;15(7):713–721.
101. Afriyie DK, Amponsah SK, Dogbey J, et al. A pilot study evaluating the prescribing of ceftriaxone in hospitals in Ghana: findings and implications. Hosp Pract. 2017;45(4):143–149.
102. National Collaborating Centre for Women’s and Children’s Health,. Surgical site infection prevention and treatment of surgical site infection. Clinical Guideline 2008. Available at https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0010039/pdf/PubMedHealth_PMH0010039.pdf [Accessed on June - 4 - 2018].
103. Tanner J, Norrie P, Melen K. Preoperative hair removal to reduce surgical site infection. Cochrane Database Syst Rev. 2011;11:CD004122.
104. Alexander JW, Fischer JE, Boyajian M, et al. The influence of hair removal methods on wound infections. Arch Surg. 1983;118(3):347–352.
105. Balthazar ER, Colt JD, Nichlos R. Preoperative hair removal: a random prospective study of shaving versus clipping. South Med J. 1982;75(7):799–801.
106. Ko W, Lazenby WD, Zelano JA, et al. Effects of shaving methods and intraoperative irrigation on suppurative mediastinitis after bypass operations. Ann Thorac Surg. 1992;53(2):301–305.
107. Breiting V, Hellberg S. Chemical depilation as an alternative to shaving. Ugeskr Laeger. 1981;143(26):1646–1647.
108. Court Brown CM. Preoperative skin depilation and its effect on postoperative wound infections. J R Coll Surg Edinb. 1981;26(4):238–241.
109. Goeau-Brissonniere O, Coignard S, Merao AP, et al. Pre-operative skin preparation a study comparing a depilatory agent in shaving. Presse Med. 1987;16(31):1517–1519.
110. Powis SJA, Waterworth T, Arkell DG. Preoperative skin preparation: clinical evaluation of depilatory cream. Br Med J. 1976;2(6045):1166–1168.
111. Seropian R, Reynolds B. Wound infections after preoperative depilatory verses razor preparation. Am J Sur. 1971;121(3):253–254.
112. Thorup J, Fischer A, Lindenberg S, et al. Chemical depilation versus shaving. A Controlled Clinical Trial of Self-Depilation in Ambulatory Surgery. Ugeskrift Fur Laeger. 1985;25(13):1108–1110.
113. Thur de Koos P, McComas B. Shaving versus skin depilatory cream for preoperative skin preparation. Am J Sur. 1983;145(3):377–378.
114. Kumar K, Thomas J, Chan C. Cosmesis in neurosurgery: is the bald head necessary to avoid postoperative infection? Ann Acad Med Singapore. 2002;31(2):150–154.
115. Broekman ML, van Beijnum J, Peul WC, et al. Neurosurgery and shaving: what’s the evidence? A review. J Neurosurg. 2011;115(4):670–678.
116. Kjonniksen I, Andersen BM, Sondenaa VG, et al. Preoperative hair removal: a systematic literature review. 2002. In: Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet]. York (UK): Centre for Reviews and Dissemination (UK); 1995. Available at https://www.ncbi.nlm.nih.gov/books/NBK68961/[Accessed on June - 4 - 2018].
117. Maksimovic J, Markovic-Denic L, Bumbasirevic M, et al. Surgical site infections in orthopedic patients: prospective cohort study. Croat Med J. 2008;49(1):58–65.
118. Niel-Weise BS, Wille JC. van den Broek PJ. Hair removal policies in clean surgery: systematic review of randomized, controlled trials. Infect. Control Hosp Epidemiol. 2005;26(12):923–928.
119. Goroncy-Bermes P, Koburger T, Meyer B. Impact of the amount of hand rub applied in hygienic hand disinfection on the reduction of microbial counts on hands. J Hosp Infect. 2010;74(3):212–218.
120. Hübner NO, Kellner NB, Partecke LI, et al. Determination of antiseptic efficacy of rubs on the forearm and consequences for surgical hand disinfection. J Hosp Infect. 2011;78(1):11–15.
121. EN 12791. Chemical disinfectants and antiseptics. Surgical hand disinfection. Test method and requirement (phase 2, step 2). Brussels: CEN e Comité Européen de Normalisation; 2005.
122. Gebel J, Werner H-P, Kirsch-Altena A, et al. Standardmethoden der DGHM zur Prüfung chemischer Desinfektionsverfahren. Wiesbaden: mhp Verlag GmbH; 2001.
123. Shenoy RM, Shenoy A. Safe surgical practices, and asepsis. Arch Med Health Sci. 2013;1(1):38–45.
124. Harpaz R, Von Seidlein L, Averhoff FM, et al. Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control. N Engl J Med. 1996;334(9):549–554.
125. Misteli H, Weber WP, Reck S, et al. Surgical glove perforation and the risk of surgical site infection. Arch Surg. 2009;144(6):553–558.
126. Bekele A, Makonnen N, Tesfaye L, et al. Incidence and patterns of surgical glove perforations: experience from Addis Ababa, Ethiopia. BMC Surg. 2017;17(1):26.
127. Guo YP, Wong PM, Li Y, et al. Is double-gloving really protective? A comparison between the glove perforation rate among perioperative nurses with single and double gloves during surgery. Am J Surg. 2012;204(2):210–215.
128. Mischke C, Verbeek JH, Saarto A, et al. Gloves, extra gloves or special types of gloves for preventing percutaneous exposure injuries in healthcare personnel. Cochrane Database Syst Rev. 2014;3:CD009573.
129. Allegranzi B, Bischoff P, de Jonge S, et al. New WHO recommendations on preoperative measures for surgical site infection prevention: an evidence-based global perspective. Lancet Infect Dis. 2016;16(12):e276–e287.
130. Allegranzi B, Zayed B, Bischoff P, et al. New WHO recommendations on intraoperative and postoperative measures for surgical site infection prevention: an evidence-based global perspective. Lancet Infect Dis. 2016;16:e288–e303.
131. Berríos-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for disease control and prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg. 2017;152:784–791.
132. Călina D, Docea AO, Rosu L, et al. Antimicrobial resistance development following surgical site infections. Mol Med Rep. 2017;15(2):681–688.
133. Chaudhary R, Thapa SK, Rana J, et al. Surgical site infections and antimicrobial resistance pattern. J Nepal Health Res Counc. 2017;15(2):120–123.
134. Yang SF, Nadimi S, Eggerstedt M, et al. Antibiotic prophylaxis and postoperative wound infection rates in salvage surgery for head and neck cancer. Head Neck Cancer Res. 2016;1:2.
135. Hirakawa H, Hasegawa Y, Hanai N, et al. Surgical site infection in clean-contaminated head and neck cancer surgery: risk factors and prognosis. Eur Arch Otorhinolaryngol. 2013;270(3):1115–1123.
136. Lotfi CJ, Cavalcanti Rde C, Costa E Silva AM, et al. Risk factors for surgical-site infections in head and neck cancer surgery. Otolaryngol Head Neck Surg. 2008;138(1):74–80.